Spots Global Cancer Trial Database for mln1117
Every month we try and update this database with for mln1117 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
MLN0128 and MLN0128 + MLN1117 Compared With Everolimus in the Treatment of Adults With Advanced or Metastatic Clear-Cell Renal Cell Carcinoma | NCT02724020 | Clear-cell Meta... | Everolimus MLN0128 MLN1117 | 18 Years - | Takeda | |
A Study of Sapanisertib, Combination of Sapanisertib With MLN1117, Paclitaxel and Combination of Sapanisertib With Paclitaxel in Women With Endometrial Cancer | NCT02725268 | Endometrial Neo... | Paclitaxel Sapanisertib MLN1117 | 18 Years - | Takeda | |
MLN0128 and MLN0128 + MLN1117 Compared With Everolimus in the Treatment of Adults With Advanced or Metastatic Clear-Cell Renal Cell Carcinoma | NCT02724020 | Clear-cell Meta... | Everolimus MLN0128 MLN1117 | 18 Years - | Takeda |